Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Despite long covid's vast reach, the federal government's investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.

Net Earnings of $51 million, or $0.36 per share Return on Average Assets of 1.30%Net Interest Margin of 3.18%Full Year 2024 ...

According to a new market research report titled, 'Risk Management Market Size, Share, Forecast, & Trends Analysis by ...

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029.

Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or “the Company”) today reported fourth quarter of 2024 net income attributable to the Company of $9.9 million, or $0.22 per diluted share. Net income ...

The National Telecommunications and Information Administration (NTIA) has recommended Merit Network for a Digital Equity ...

Our Top PicksLifeLockIdentity Guard®AuraIt is much easier and safer to prevent identity theft than try to fix it later.